Luxcel Biosciences Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Luxcel Biosciences General Information

Description

Developer of real-time fluorescence plate-reader. The company's real-time fluorescence plate-reader is focused on porphyrin-based, phosphorescent, oxygen-sensing probes and oxygen sensors, with initial applications targeted at the pharmaceutical, food safety and packaging industries, enabling them to transform existing specialised tests, into new, high performance but affordable and easy-to-use products.

Contact Information

Website
www.luxcel.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Hoffmann Park, Inchera
  • Little Island
  • Cork
  • Ireland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luxcel Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 09-Jan-2018 00.000 Completed Generating Revenue
4. Grant 03-Jul-2017 00.000 00.000 Completed Generating Revenue
3. Grant 13-Aug-2015 00.000 00.000 Completed Generating Revenue
2. Later Stage VC 21-Jan-2010 $3.59M $7.68M 00000 Completed Generating Revenue
1. Later Stage VC 01-Jan-2009 $4.09M $4.09M Completed Generating Revenue
To view Luxcel Biosciences’s complete valuation and funding history, request access »

Luxcel Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of real-time fluorescence plate-reader. The company's real-time fluorescence plate-reader is focused on porphy
Biotechnology
Cork, Ireland
00.000
000000&0 00.000

000000

d exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000 000000000
South San Francisco, CA
0 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
00000 0000000000 000
San Diego, CA
00 As of 0000
0000
000.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Luxcel Biosciences Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Superfluid DX Venture Capital-Backed South San Francisco, CA 0 000.00 00000000000 000.00
Mindera Health Venture Capital-Backed San Diego, CA 00 0000 00000000000 0000
Asuragen Formerly VC-backed Austin, TX 000 000.00 000000&0 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Luxcel Biosciences Patents

Luxcel Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210154664-A1 Headspace eliminating microtiter plate lid and method of optically measuring well oxygen concentration through the lid Pending 16-May-2017 00000000000 0
US-20200166529-A1 Real-time cellular or pericellular microenvironmental oxygen control Pending 10-May-2017 000000000
EP-2783202-A1 Device and method for rapid assay of multiple biological samples for oxygen consumption Inactive 22-Nov-2011 00000000000
EP-2786128-A1 Dry laminated photoluminescent probe and methods of manufacture and use Inactive 06-Sep-2011 000000000 0
EP-2737076-A1 Method and device for detection and quantification of thermoduric microorganisms in a product Active 18-Jul-2011 C12Q1/04
To view Luxcel Biosciences’s complete patent history, request access »

Luxcel Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Enterprise Ireland Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Mocon Corporation Minority 000 0000 000000 0
To view Luxcel Biosciences’s complete investors history, request access »

Luxcel Biosciences FAQs

  • When was Luxcel Biosciences founded?

    Luxcel Biosciences was founded in 2002.

  • Who is the founder of Luxcel Biosciences?

    Richard Fernandes Ph.D and Dimitri Papkovsky are the founders of Luxcel Biosciences.

  • Where is Luxcel Biosciences headquartered?

    Luxcel Biosciences is headquartered in Cork, Ireland.

  • What industry is Luxcel Biosciences in?

    Luxcel Biosciences’s primary industry is Biotechnology.

  • Is Luxcel Biosciences a private or public company?

    Luxcel Biosciences is a Private company.

  • What is Luxcel Biosciences’s current revenue?

    The current revenue for Luxcel Biosciences is 000000.

  • How much funding has Luxcel Biosciences raised over time?

    Luxcel Biosciences has raised $7.68M.

  • Who are Luxcel Biosciences’s investors?

    Enterprise Ireland, Horizon 2020 SME Instrument, and Mocon have invested in Luxcel Biosciences.

  • Who are Luxcel Biosciences’s competitors?

    Superfluid DX, Mindera Health, and Asuragen are competitors of Luxcel Biosciences.

  • When was Luxcel Biosciences acquired?

    Luxcel Biosciences was acquired on 09-Jan-2018.

  • Who acquired Luxcel Biosciences?

    Luxcel Biosciences was acquired by Agilent Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »